Home
About
Services
Partners
Client Portfolio
News
Contact
Nigeria’s oil hub quarantines 22 Exxon Mobil workers: governor
April 17, 2020
GE aircraft leasing unit cancels 69 737 MAX orders
April 17, 2020
0
Gilead’s shares rise on report of experimental drug’s promise in COVID-19
Published by
Muller&Green
at
April 17, 2020
Categories
RSS
Tags
Shares of Gilead Sciences Inc rose 8% on Friday after a report that patients with COVID-19 treated with the company’s experimental drug, remdesivir, in a clinical trial showed rapid recovery in fever and respiratory symptoms.
Powered by
WPeMatico
Muller&Green
Related posts
December 17, 2024
Five Lessons From My Mentor
Read more
December 13, 2024
Where Does Corporate Climate Action Go Next?
Read more
December 12, 2024
CEO of the Year Lisa Su Talks Competition and Collaboration in the Semiconductor Industry
Read more